RMD Stock ResMed Inc.
US · NYSELast in our picks 2026-10-02 — not in the current list; analysis below is from that screen
Sleep-apnea leader with strong momentum, operating leverage, and ongoing demand recovery.
Future value: $250.22 (+13.15%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Positive momentum and recurring demand tailwinds.
- ▾Below 50-day MA (-0.71%)
Is RMD a buy right now?
Trend: RMD is trading above the 50-day average (+10.03%), RSI 29 — oversold territory, with a 3-month return of +21.17%.
Valuation & quality: ResMed Inc. trades on a trailing P/E of 24.3, forward P/E 19.1, PEG 1.47, price-to-book 5.55; fundamentals show net margin 26.9%, return on equity 24.3%, revenue growth 8.6% year on year.
Analyst consensus: 17 analysts have a mean 12-month price target of $251.52 (-0.7% vs the last close; range $175.00 – $320.00), consensus rating “buy”.
Income: trailing dividend yield 1.04%.
Our screen: BUY (score 2) — Sleep-apnea leader with strong momentum, operating leverage, and ongoing demand recovery.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -12.40% | -4.80% | -10.90% | +2.30% | +8.30% | +13.80% | -7.90% | +14.50% |
Fundamentals
Analyst price target
Technical signals
About ResMed Inc.
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 11,370 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.